Leaders in Pharmaceutical Business Intelligence (LPBI) Group

We Celebrate +750,000 e-Readers

@ Leaders in Pharmaceutical Business Intelligence (LPBI)

Aviva Lev-Ari, PhD, RN

Director & Founder

Leaders in Pharmaceutical Business Intelligence, Boston

http://pharmaceuticalintelligence.com

@pharma_BI

Co-Founder, GDE, 

Boston, USA & Lausanne, Switzerland

e-Mail: avivalev-ari@alum.berkeley.edu

SkypeID: HarpPlayer83

@pharma_BI

Our e-Readers are interested in our

BioMed e-Series of e-Books

http://pharmaceuticalintelligence.com/biomed-e-books/

Our e-Readers benefit from the unique

e-Publishing Process we use. The Process is described in

By Design: A BRANDING Engine “Hard-wired” in the Ontology of an Open Access Online Scientific Journal @ Leaders in Pharmaceutical Business Intelligence (LPBI)

 > than 1,500 e-Readers on 10/5/2015  for  Our

TOP Articles by  Article Title and # of Views

Article Title                                           Views                 

11,258

Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?

5,361

Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)

4,693

Our TEAM

4,482

Recent comprehensive review on the role of ultrasound in breast cancer management

3,944

Mesothelin: An early detection biomarker for cancer (By Jack Andraka)

3,376

Paclitaxel vs Abraxane (albumin-bound paclitaxel)

3,201

Volume One: Perspectives on Nitric Oxide in Disease Mechanisms

2,986

Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses

2,801

Founder

2,769

AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo

2,619

BioMed e-Series

2,431

Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad

2,393

Akt inhibition for cancer treatment, where do we stand today?

2,380

The mechanism of action of the drug ‘Acthar’ for Systemic Lupus Erythematosus (SLE)

2,225

Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology

2,013

About

2,011

Funding, Deals & Partnerships

2,001

VISION

1,893

Problems of vegetarianism

1,872

“The Molecular pathology of Breast Cancer Progression”

1,800

Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community

1,763

The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets

1,692

Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care

1,628

Bone regeneration and nanotechnology

1,620

Journal PharmaceuticalIntelligence.com

1,614

Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I

1,610

Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation

1,588

FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules

1,526

Treatment Options for Left Ventricular Failure – Temporary Circulatory Support: Intra-aortic balloon pump (IABP) – Impella Recover LD/LP 5.0 and 2.5, Pump Catheters (Non-surgical) vs Bridge Therapy: Percutaneous Left Ventricular Assist Devices (pLVADs) and LVADs (Surgical)

1,496

Biosimilars: CMC Issues and Regulatory Requirements

Meet Our Experts, Authors, Writers

Select All	Username	Name	E-mail	Role	Posts
2012pharmaceutical	2012pharmaceutical	Aviva Lev-Ari, PhD, RN	avivalev-ari@alum.berkeley.edu	Administrator	2123 posts by this author
Select aashirawan	aashirawan	Aashir Awan	aashir_awan@hotmail.com	Author	44 posts by this author
Select alankaul	alankaul	Alan Kaul	alan.kaul@comcast.net	Author	4 posts by this author
Select anamikasarkar	anamikasarkar		sarkaranamika@yahoo.com	Author	7 posts by this author
Select apreconasia	apreconasia	MICHAEL WARD	apreconasia@gmail.com	Author	2 posts by this author
Select aviralvatsa	aviralvatsa		aviralvatsa@gmail.com	Author	20 posts by this author
Select danutdaagmailcom	danutdaagmailcom	Danut Dragoi	danut.daa@gmail.com	Author	5posts by this author
Select demetsag	demetsag	Demet Sag	demet.sag@gmail.com	Author	24 posts by this author
Select drornir0305	drornir0305	Dror Nir	drornir0305@gmail.com	Editor	55 posts by this author
Select gerag2015	gerag2015	Gérard Henri LOISEAU	gerard.loiseau@bluewin.ch	Author	3
Select irirobu	irirobu	Irina	irina.stefania@gmail.com	Author	6 posts by this author
Select jdpmd	jdpmd	Justin Pearlman	jdpmdphd@gmail.com	Editor	4 posts by this author
Select jukkakarjalainen	jukkakarjalainen		jukka.karjalainen@rogers.com	Author	1 post by this author
Select kislauskis	kislauskis	Ed Kislauskis	ekislauskis@hotmail.com	Author	1 post by this author
Select kullback	kullback	Larry Bernstein	larry.bernstein@gmail.com	Editor	714 posts by this author
Select ltcolvivek	ltcolvivek		ltcolvivek@gmail.com	Author	0
Select megbaker58	megbaker58	Margaret (Meg) Baker	meg.baker58@gmail.com	Author	4

Select pkandala	pkandala	Prabodh kumar Kandala	prabodh.kandala@gmail.com	Author	43 posts by this author
Select ritusaxena	ritusaxena	Ritu Saxena	ritu.uab@gmail.com	Editor	40 posts by this author
Select sjwilliamspa	sjwilliamspa		sjwilliamspa@comcast.net	Editor	91 posts by this author
Select sudiptasaha1977	sudiptasaha1977	Sudipta Saha	sudiptasaha1977@gmail.com	Author	58 posts by this author
Select tildabarliya	tildabarliya	Tilda Barliya	tildabarliya@gmail.com	Editor	46 posts by this author
Select zraviv06	zraviv06		zraviv06@gmail.com	Author	9 posts by this author